全球局部药物 CDMO 市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势和预测

全球外用药物 CDMO 市场的需求预计将从 2022 年的 375.8 亿美元增至 2030 年的近 966.9 亿美元，2023-2030 年研究期间的CAGR为 12.54%。

外用药品CDMO是指专门为外用药品提供合约开发和製造外包服务的公司或组织。 CDMO 代表合约开发和製造组织，这些实体专门透过提供与药物开发、製造（有时甚至是商业化）相关的服务来支援製药和生物技术产业。

市场动态：

由于几个关键因素，外用药物合约开发和製造组织 (CDMO) 市场正在蓬勃发展。药物开发的复杂性日益增加，特别是外用药物的配方设计，促使製药公司利用 CDMO 的专业知识。成本效率是一个重要的驱动因素，因为外包给外用药物 CDMO 无需大量内部投资即可获得专业服务和基础设施。对核心能力的关注使製药公司能够专注于研究和行销，同时依靠 CDMO 来开发和製造外用药物。对外用药品的需求不断增长、製剂技术的进步以及监管合规的必要性进一步促进了该市场的成长。製药业的全球化、灵活性、可扩展性和外包趋势凸显了外用药物 CDMO 在加快药物开发进度和有效满足市场需求方面的关键作用。随着製药公司寻求策略合作伙伴关係以应对不断变化的形势，外用药物 CDMO 成为药品供应链中的重要合作者。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球外用药物 cdmo 市场的每个细分市场进行了包容性评估。外用药物 cdmo 产业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲局部药物 CDMO 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。外用药物 CDMO 市场的主要参与者包括 Lubrizol Life Science、Cambrex Corporation、Contract Pharmaceuticals Limited、Bora Pharmaceutical CDMO、Ascendia Pharmaceuticals、Pierre Fabre group、Piramal Pharma Solutions、DPT Laboratories, LTD.、MedPharm Ltd.、PCIgroup、Piramal Pharma Solutions、DPT Laboratories, LTD.、MedPharm Ltd.、PCIgroup Pharma Services。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：外用药物 CDMO - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 市场吸引力分析：按产品类型
  • 按服务类型分類的市场吸引力分析
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球局部药物 CDMO 市场分析：依产品类型

• 概述：按产品类型
• 历史和预测数据
• 分析：依产品类型
• 半固体製剂（霜剂、软膏剂、凝胶剂、其他）
• 液体製剂药物
• 固体製剂
• 透皮产品

第 6 章：全球专题药物 CDMO 市场分析：依服务类型

• 按服务类型概述
• 历史和预测数据
• 按服务类型分析
• 合约开发
• 合约起草（名词

第 7 章：全球局部药物 CDMO 市场分析：依最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 製药公司
• 生物製药公司
• 其他的

第 8 章：全球局部药物 CDMO 市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：局部药品 CDMO 公司的竞争格局

• 外用药物Cdmo市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Lubrizol Life Science
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Cambrex Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Contract Pharmaceuticals Limited
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bora Pharmaceutical CDMO
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Ascendia Pharmaceuticals
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Pierre Fabre group
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Piramal Pharma Solutions
• 公司简介
• 公司收入
• 产品
• 最近的发展
• DPT Laboratories LTD.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• MedPharm Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• PCI Pharma Services
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Topical Drugs CDMO Market is presumed to reach the market size of nearly USD 96.69 BN by 2030 from USD 37.58 BN in 2022 with a CAGR of 12.54% under the study period 2023 - 2030.

Topical drugs CDMO refers to companies or organizations that provide Contract Development and Manufacturing Outsourcing services specifically for topical pharmaceutical drugs. CDMO stands for Contract Development and Manufacturing Organization, and these entities specialize in supporting the pharmaceutical and biotechnology industries by offering services related to the development, manufacturing, and sometimes commercialization of drugs.

MARKET DYNAMICS:

The Topical Drugs Contract Development and Manufacturing Organization (CDMO) market is thriving due to several key factors. The increasing complexity of drug development, particularly in the formulation design for topical drugs, propels pharmaceutical companies to leverage the specialized expertise of CDMOs. Cost efficiency is a significant driver, as outsourcing to Topical drugs CDMOs provides access to specialized services and infrastructure without substantial in-house investments. The focus on core competencies allows pharmaceutical companies to concentrate on research and marketing while relying on CDMOs for the development and manufacturing of topical drugs. The rising demand for topical drug products, advancements in formulation technologies, and the imperative of regulatory compliance further contribute to the growth of this market. Globalization, flexibility, scalability, and the trend of outsourcing in the pharmaceutical industry underscore the pivotal role of Topical drugs CDMOs in accelerating drug development timelines and meeting market demands efficiently. As pharmaceutical companies seek strategic partnerships to navigate the evolving landscape, Topical drugs CDMOs emerge as crucial collaborators in the pharmaceutical supply chain.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of topical drugs cdmo. The growth and trends of topical drugs cdmo industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the topical drugs cdmo market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Semi-Solid Formulations (Creams, Ointments, Gel, Others)
• Liquid Formulations Drugs
• Solid Formulations
• Transdermal Products

By Service Type

• Contract Development
• Contract Manufacturing

By End-Use

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Topical Drugs CDMO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Topical Drugs CDMO market include Lubrizol Life Science, Cambrex Corporation, Contract Pharmaceuticals Limited, Bora Pharmaceutical CDMO, Ascendia Pharmaceuticals, Pierre Fabre group, Piramal Pharma Solutions, DPT Laboratories, LTD., MedPharm Ltd., PCI Pharma Services. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . TOPICAL DRUGS CDMO - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Service Type
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL TOPICAL DRUGS CDMO MARKET ANALYSIS BY PRODUCT TYPE

• 5.1 Overview by Product Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product Type
• 5.4 Semi-solid Formulations (Creams, Ointments, Gel, Others) Historic and Forecast Sales by Regions
• 5.5 Liquid Formulations Drugs Historic and Forecast Sales by Regions
• 5.6 Solid Formulations Historic and Forecast Sales by Regions
• 5.7 Transdermal Products Historic and Forecast Sales by Regions

6 . GLOBAL TOPICAL DRUGS CDMO MARKET ANALYSIS BY SERVICE TYPE

• 6.1 Overview by Service Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Service Type
• 6.4 Contract Development Historic and Forecast Sales by Regions
• 6.5 Contract Manufacturing Historic and Forecast Sales by Regions

7 . GLOBAL TOPICAL DRUGS CDMO MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
• 7.5 Biopharmaceutical Companies Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL TOPICAL DRUGS CDMO MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE TOPICAL DRUGS CDMO COMPANIES

• 9.1. Topical Drugs Cdmo Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF TOPICAL DRUGS CDMO INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Lubrizol Life Science
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Cambrex Corporation
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Contract Pharmaceuticals Limited
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Bora Pharmaceutical CDMO
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Ascendia Pharmaceuticals
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Pierre Fabre group
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Piramal Pharma Solutions
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. DPT Laboratories LTD.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. MedPharm Ltd.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. PCI Pharma Services
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product Type (USD MN)
• Semi-solid Formulations (Creams, Ointments, Gel, Others) Market Sales by Geography (USD MN)
• Liquid Formulations Drugs Market Sales by Geography (USD MN)
• Solid Formulations Market Sales by Geography (USD MN)
• Transdermal Products Market Sales by Geography (USD MN)
• Analysis Market by Service Type (USD MN)
• Contract Development Market Sales by Geography (USD MN)
• Contract Manufacturing Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Pharmaceutical Companies Market Sales by Geography (USD MN)
• Biopharmaceutical Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Topical Drugs Cdmo Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Topical Drugs Cdmo Report
• Market Research Process
• Market Research Methodology
• Global Topical Drugs Cdmo Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product Type
• Market Attractiveness Analysis by Service Type
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product Type (USD MN)
• Semi-solid Formulations (Creams, Ointments, Gel, Others) Market Sales by Geography (USD MN)
• Liquid Formulations Drugs Market Sales by Geography (USD MN)
• Solid Formulations Market Sales by Geography (USD MN)
• Transdermal Products Market Sales by Geography (USD MN)
• Global Market Analysis by Service Type (USD MN)
• Contract Development Market Sales by Geography (USD MN)
• Contract Manufacturing Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Pharmaceutical Companies Market Sales by Geography (USD MN)
• Biopharmaceutical Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.